Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies

BACKGROUND: Hyperimmune convalescent COVID-19 plasma (CCP) containing anti-SARS-CoV-2 neutralizing antibodies (NAbs) was proposed as a therapeutic option for patients early in the new coronavirus disease pandemic. The efficacy of this therapy depends on the quantity of neutralizing antibodies (NAbs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jazbec, Katerina, Jež, Mojca, Žiberna, Klemen, Mali, Polonca, Ramšak, Živa, Potokar, Urška Rahne, Kvrzić, Zdravko, Černilec, Maja, Gracar, Melita, Šprohar, Marjana, Jovanovič, Petra, Vuletić, Sonja, Rožman, Primož
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042109/
https://www.ncbi.nlm.nih.gov/pubmed/36973781
http://dx.doi.org/10.1186/s12985-023-02007-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042109/
https://www.ncbi.nlm.nih.gov/pubmed/36973781
http://dx.doi.org/10.1186/s12985-023-02007-0

Ejemplares similares